PM
49
8
KMI
69
8
FSLR
50
6
SLG
37
6
PCG
59
9
MCD
52
3
AES
47
4
ABBV
40
5
BF.B
35
2
ILMN
31
4
PEP
33
4
TXT
46
4
NI
63
5
LUV
45
3
ORLY
48
3
SIG
52
5
IBM
53
2
LEG
16
2
MDT
59
4
HOG
29
4
PM
49
8
KMI
69
8
FSLR
50
6
SLG
37
6
PCG
59
9
MCD
52
3
AES
47
4
ABBV
40
5
BF.B
35
2
ILMN
31
4
PEP
33
4
TXT
46
4
NI
63
5
LUV
45
3
ORLY
48
3
SIG
52
5
IBM
53
2
LEG
16
2
MDT
59
4
HOG
29
4
Financhill
Back

TG Therapeutics Quote, Financials, Valuation and Earnings

How to Turn the AI Energy Crisis into BIG Profits

And investors who move now into one technology could make a whole lot of money.
Buy
60

TGTX
TG Therapeutics

Last Price:
$32.22
Seasonality Move:
63.62%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's Legacy-Defining Momentor Strike

But the Surprising Way Trump Solves it Could Cement His Legacy.

TG Therapeutics Price Quote

$32.22

TG Therapeutics Key Stats

Buy
60
TG Therapeutics (TGTX) is a Buy
Day range:
$30.50 - $32.63
52-week range:
$12.84 - $36.84
Dividend yield:
0%
P/E ratio:
358.00
P/S ratio:
18.94
P/B ratio:
26.1%
Volume:
2.7M
Avg. volume:
3.1M
1-year change:
87.22%
Market cap:
$5B
Revenue:
$233.7M
EPS:
$-0.11

How Much Does TG Therapeutics Make?

Data Unavailable

Is TG Therapeutics Growing As A Company?

Data Unavailable

TG Therapeutics Stock Price Performance

  • Did TG Therapeutics Stock Go Up Last Month?
    TG Therapeutics share price went up by 3.44% last month
  • Did TGTX's Share Price Rise Over The Last Year?
    TGTX share price rose by 87.22% over the past 1 year

What Is TG Therapeutics 52-Week High & Low?

TG Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy TG Therapeutics?

Data Unavailable

Is TG Therapeutics Cash Flow Positive?

Data Unavailable

TG Therapeutics Return On Invested Capital

Data Unavailable

TG Therapeutics Earnings Date & Stock Price

TG Therapeutics Competitors

  • Who Are TG Therapeutics's Competitors?
    Below is a list of companies who compete with TG Therapeutics or are related in some way:
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Rhythm Pharmaceuticals Inc (RYTM)
    • Warby Parker Inc (WRBY)
    • Zoetis Inc (ZTS)

TG Therapeutics Dividend Yield

Data Unavailable

TG Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: -97.26% -40.92%
Revenue: -49.41% 2.66%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable